Price movement over the last 24 hours
Agilent Technologies Inc vs abrdn Physical Palladium Shares ETF — how do they compare? Agilent Technologies Inc trades at $128.5 (market cap $37.04B), while abrdn Physical Palladium Shares ETF trades at $22.1. The key difference: Agilent Technologies Inc pays a 0.78% dividend while abrdn Physical Palladium Shares ETF pays none, and Agilent Technologies Inc is trading nearer its 52-week high, abrdn Physical Palladium Shares ETF nearer its low. Which is the better fit depends on your goals.
| A | PALL | |
|---|---|---|
Market Cap | $37.04B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $157.20 | $37.18 |
52-Week Low | $110.24 | $19.96 |
Enterprise Value | $38.59B | — |
Dividend Yield | 0.78% | — |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
PALL trades at $23.15, up 1.05% today, but technical indicators signal a bearish trend with moving averages and oscillators in sell territory. A 1-for-5 stock split is scheduled for May 18, 2026. Recent news highlights palladium's price weakness as a potential buying opportunity, citing supply risks and industrial demand. The stock faces headwinds from Federal Reserve rate hike expectations and weaker investment demand.
The outlook remains cautious due to bearish technicals and macroeconomic pressures, though some analysts see value at current levels. Key risks include commodity price volatility and interest rate sensitivity. Investors should weigh the ETF's exposure to palladium's supply-demand dynamics against broader market sentiment.
Trailing returns across standard periods
Latest headlines on both assets
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →PALL is a physically-backed ETF that tracks the spot price of palladium. It holds physical bullion in secure vaults, offering a liquid way to invest in this precious metal primarily used in automotive catalytic converters and electronics.
Read more on PALL →